05 April 2022 | News
Strengthens its presence in women’s health
Image credit: Shutterstock
Bharat Serums and Vaccines (BSV) has acquired Tidilan (Isoxsuprine hydrochloride), a leading brand in women’s health from Jagdale Industries, Bengaluru. Tidilan is currently available in tablet and injectable dosage forms. BSV has some of the leading women’s health brands such as Rhoclone, Hucog, Hucog 5000 HP, AntiD among others.
Tidilan (Isoxsuprine hydrochloride) is used for relaxing uterine muscles to prevent premature labour, among expecting mothers.
Sanjiv Navangul, MD and CEO, Bharat Serums & Vaccines, said, “This will be an important milestone towards our goal of being the top three women’s health players in India and as we continue to bring treatments and cures that help serve our patients better.”
Rajesh Jagdale, CMD, Jagdale Industries, added, “We are proud of our market-leading brand, Tidilan (Isoxsuprine hydrochloride) and are delighted with this partnership with BSV as we are confident that this will expand BSV’s offerings in women’s health as they work towards bringing more products that will improve lives of women in the country.”